课题基金 / 基金详情

NMDA Receptor Hypofunction in the Amygdala of Schizophrenia Patients

NMDA Receptor Hypofunction in the Amygdala of Schizophrenia Patients
精神分裂症患者杏仁核 NMDA 受体功能减退
批准号:
8887154
负责人:
Chang-Gyu Hahn
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-08 至 2017-05-31

项目摘要

项目成果

Chang-Gyu Hahn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Accumulating evidence suggests that negative symptoms of schizophrenia may be mediated by altered circuit activity in the amygdala; specifically the basolateral amygdala (BLA) -nucleus accumbens (NA) and BLA- central nucleus (CeA) connections. Given that circuit activity is governed by synaptic strength/plasticity, NMDA receptor function, a key modulator of synaptic plasticity, may play a pivotal role in the BLA-NA and BLA-CeA circuitry. NMDA receptor function is linked to an array of neurocognitive functions and can induce endophenotypic behaviors of schizophrenia when perturbed in specific brain regions. We postulate that altered synaptic connectivity associated with dysregulated NMDA receptor function in the BLA-NA and BLA- CeA circuitry may lead to negative symptoms of schizophrenia. The BLA circuitry receives robust Dl and D2R mediated input from the prefrontal cortex and striatum and its overall activity is regulated by feedfoward and feedback inhibition via GABAergic neurons in intercalated islands. Cell type specific assessment of dopaminergic and NMDA receptor signaling therefore can reveal the intercellular dynamics leading to faulty circuitry of the amygdala in schizophrenia. To address this, we propose a postmortem study in which we conduct histologic and biochemical assessment of the synaptic strength and signaling activity of NMDA and dopaminergic receptors in a cell type specific manner. In the postmortem amygdala of 30 schizophrenia subjects and their matched controls, we will examine dendritic spine density and the integrity of synapses in principal and interneurons separately. Evaluation of receptor signaling in postmortem brains has been a challenging task. We have recently developed a number of paradigms that permit us to do so and found attenuation in tyrosine phosphorylation of NMDAR2A/2B reduced Src activity and altered protein interactions of NMDA receptor complexes in the PFC of SCZ patients. In this project we will examine the NMDA receptor function using immunoprecipitation -SRM-Mass spec analysis. Dopaminergic signaling can impact on NMDA receptor signaling in principal and interneurons modulating the overall circuit activity. We will examine presynaptic and postsynaptic segments of dopaminergic input using histologic and biochemical assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia
  • 批准号:
    10321200
  • 项目类别:
  • 资助金额:
    $60.93万
  • 财政年份:
    2019
  • 负责人:
    Chang-Gyu Hahn
  • 依托单位:
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia
  • 批准号:
    9926314
  • 项目类别:
  • 资助金额:
    $64.8万
  • 财政年份:
    2019
  • 负责人:
    Chang-Gyu Hahn
  • 依托单位:
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia
  • 批准号:
    10545764
  • 项目类别:
  • 资助金额:
    $60.93万
  • 财政年份:
    2019
  • 负责人:
    Chang-Gyu Hahn
  • 依托单位:
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia
  • 批准号:
    10064372
  • 项目类别:
  • 资助金额:
    $68.8万
  • 财政年份:
    2019
  • 负责人:
    Chang-Gyu Hahn
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: